Event Type: The management/officials of Mankind Pharma Limited will participate in an Investor Conference hosted by Ashika Stock Services Limited. The meeting format will include One-on-One and Group Meetings with investors and analysts.
Date and Time: The event is scheduled for November 5, 2026. The specific time and time zone were not disclosed in the announcement.
Purpose of Event: The participation is for general investor outreach. The discussion will be based on the company's general business outlook and information already available in the public domain.
UPSI Disclosure: The company explicitly states that during the meeting with investors/analysts, no unpublished price sensitive information (UPSI) shall be disclosed. All information shared will already be available in the public domain.
Management Participants: The announcement does not specify which particular management members or officials will be participating in the conference.
Presentation Availability: The document does not indicate that any presentation, earnings deck, transcript, or recording will be made available from this event.
Additional Notes Section:
The intimation was filed pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company noted that the participation was finalized at short notice, necessitating this regulatory filing.
The schedule of the investor conference is subject to change due to exigencies on either side.
No financial data, performance figures, or strategic updates were disclosed in this announcement.
The intimation has been uploaded to the company's website at www.mankindpharma.com.
The letter was signed by Hitesh Kumar Jain, Company Secretary & Compliance Officer, on November 3, 2026.
